Mylan Pharmaceuticals Inc recalls
5 recalls filed under Mylan Pharmaceuticals Inc. The most recent was published September 9, 2026.
-
Class II · last month
Mylan Pharmaceuticals Inc Carton label: Mycophenolate Mofetil for injection, USP recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · last month
Mylan Pharmaceuticals Inc Prasugrel Tablets, USP, 10mg recall: Failed Dissolution Specifications; product failed to meet 18-month stability
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
-
Class II · 2 months ago
Mylan Pharmaceuticals Inc Acamprosate Calcium, Delayed-Release Tablets, 333 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 3 months ago
Mylan Pharmaceuticals Inc Mycophenolate Mofetil for Injection USP, 500 mg/Vial recall: Presence of precipitate
Presence of precipitate
-
Class II · 8 months ago
Mylan Pharmaceuticals Inc Amnesteem Capsules, USP 40 mg recall: Failed Dissolution Specifications
Failed Dissolution Specifications
About this page
Mylan Pharmaceuticals Inc appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.